Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EORTC CLTF 2021 | Immunoscore®: classifying patients based on immune characteristics

Jérôme Galon • 14 Oct 2021
EORTC CLTF 2021
Cutaneous T-Cell Lymphoma Lymphoma Non-Hodgkin Lymphoma Rare Diseases

Jérôme Galon, MD, PhD, Inserm, Paris, France, discusses the Immunoscore® assay, which is based on three characteristics of the cancer immune contexture: the types, the location, and the density of immune cells. Dr Galon describes how the assay is used to classify patients based on their immune characteristics. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.

More from Jérôme Galon

1:05
The future of immuno-oncology
Jérôme Galon • 14 Oct 2021
2:25
The prognostic value of memory T-cell reactions
Jérôme Galon • 14 Oct 2021
1:20
The cancer immune contexture
Jérôme Galon • 14 Oct 2021
1:44
Immune escape mechanisms in human cancers
Jérôme Galon • 14 Oct 2021

Related Videos

3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
2:11
The role of CAR-T therapy for lymphoma in 2024: expert session highlights
Sridhar Chaganti • 16 Apr 2024
3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals